| abstract |
Disclosed is a retinoid prodrug compound represented by the following general formula (I) having a property of being converted into a retinoid after absorption in a living body, which, per se, has substantially no retinoid action, or has weak retinoid action, but is converted into a potent retinoid by an enzymatic chemical modification after absorption in a living body. |